BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 8774881)

  • 41. Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1).
    Wolff S; Harper PA; Wong JM; Mostert V; Wang Y; Abel J
    Mol Pharmacol; 2001 Apr; 59(4):716-24. PubMed ID: 11259615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
    Wells RG; Gilboa L; Sun Y; Liu X; Henis YI; Lodish HF
    J Biol Chem; 1999 Feb; 274(9):5716-22. PubMed ID: 10026191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.
    Penheiter SG; Mitchell H; Garamszegi N; Edens M; Doré JJ; Leof EB
    Mol Cell Biol; 2002 Jul; 22(13):4750-9. PubMed ID: 12052882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor-regulated Smads in TGF-beta signaling.
    Liu F
    Front Biosci; 2003 Sep; 8():s1280-303. PubMed ID: 12957874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Drosophila activin receptor baboon signals through dSmad2 and controls cell proliferation but not patterning during larval development.
    Brummel T; Abdollah S; Haerry TE; Shimell MJ; Merriam J; Raftery L; Wrana JL; O'Connor MB
    Genes Dev; 1999 Jan; 13(1):98-111. PubMed ID: 9887103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.
    Huse M; Muir TW; Xu L; Chen YG; Kuriyan J; Massagué J
    Mol Cell; 2001 Sep; 8(3):671-82. PubMed ID: 11583628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing.
    Hao J; Ju H; Zhao S; Junaid A; Scammell-La Fleur T; Dixon IM
    J Mol Cell Cardiol; 1999 Mar; 31(3):667-78. PubMed ID: 10198196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.
    Fernandez T; Amoroso S; Sharpe S; Jones GM; Bliskovski V; Kovalchuk A; Wakefield LM; Kim SJ; Potter M; Letterio JJ
    J Exp Med; 2002 May; 195(10):1247-55. PubMed ID: 12021305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How many receptors does it take?
    Wharton KA
    Bioessays; 1995 Jan; 17(1):13-6. PubMed ID: 7702589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins.
    Chen Y; Lebrun JJ; Vale W
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12992-7. PubMed ID: 8917532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New insights into TGF-beta-Smad signalling.
    ten Dijke P; Hill CS
    Trends Biochem Sci; 2004 May; 29(5):265-73. PubMed ID: 15130563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3.
    Besser D
    J Biol Chem; 2004 Oct; 279(43):45076-84. PubMed ID: 15308665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest.
    Petritsch C; Beug H; Balmain A; Oft M
    Genes Dev; 2000 Dec; 14(24):3093-101. PubMed ID: 11124802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TGF-beta signaling, tumor suppression, and acute lymphoblastic leukemia.
    Downing JR
    N Engl J Med; 2004 Aug; 351(6):528-30. PubMed ID: 15295044
    [No Abstract]   [Full Text] [Related]  

  • 55. From receptor to nucleus: the Smad pathway.
    Baker JC; Harland RM
    Curr Opin Genet Dev; 1997 Aug; 7(4):467-73. PubMed ID: 9309176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Smad inhibition by the Ste20 kinase Misshapen.
    Kaneko S; Chen X; Lu P; Yao X; Wright TG; Rajurkar M; Kariya K; Mao J; Ip YT; Xu L
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11127-32. PubMed ID: 21690388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3.
    Wilkes MC; Murphy SJ; Garamszegi N; Leof EB
    Mol Cell Biol; 2003 Dec; 23(23):8878-89. PubMed ID: 14612425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MADR1, a MAD-related protein that functions in BMP2 signaling pathways.
    Hoodless PA; Haerry T; Abdollah S; Stapleton M; O'Connor MB; Attisano L; Wrana JL
    Cell; 1996 May; 85(4):489-500. PubMed ID: 8653785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster.
    Bennett D; Alphey L
    Nat Genet; 2002 Aug; 31(4):419-23. PubMed ID: 12134149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TGF-beta receptors and signalling mechanisms.
    Wrana JL
    Miner Electrolyte Metab; 1998; 24(2-3):120-30. PubMed ID: 9525694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.